Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    17287478 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed
Has Results
A Safety and Effectiveness Study of CNTO 1275 in Patients With Moderate to Severe Plaque-type Psoriasis
Condition: Psoriasis
Interventions: Drug: Ustekinumab;   Drug: Placebo

Indicates status has not been verified in more than two years